16 hours Ago By ABMN Staff
Forte Biosciences, Inc. ( NASDAQ:FBRX – Get Free Report ) was the recipient of some unusual options trading activity on Wednesday. Investors acquired 30,205 call options on the company.
This is an increase of 1,663% compared to the typical daily volume of 1,713 call options. Insider Activity In other news, CFO Antony A. Riley acquired 22,514 shares of Forte Biosciences stock in a transaction dated Thursday, November 21st.
The stock was purchased at an average cost of $5.55 per share, for a total transaction of $124,952.70.
Following the completion of the purchase, the chief financial officer now directly owns 30,776 shares in the company, valued at $170,806.80. This trade represents a 272.
50 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link . Corporate insiders own 9.
60% of the company’s stock. Wall Street Analyst Weigh In Separately, Chardan Capital reissued a “buy” rating and set a $64.00 price target on shares of Forte Biosciences in a research report on Wednesday, December 4th.
Forte Biosciences Stock Performance Shares of FBRX opened at $19.70 on Thursday. The business’s 50-day moving average is $13.
06 and its two-hundred day moving average is $6.13. The company has a market capitalization of $28.
80 million, a P/E ratio of -1.21 and a beta of 1.08.
Forte Biosciences has a fifty-two week low of $4.11 and a fifty-two week high of $28.68.
Forte Biosciences Company Profile ( Get Free Report ) Forte Biosciences, Inc operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc is headquartered in Dallas, Texas.
Recommended Stories Receive News & Ratings for Forte Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forte Biosciences and related companies with MarketBeat.com's FREE daily email newsletter ..
